|
|
|
Insider
Information: |
Bird Jeffrey W |
Relationship: |
Director, 10% Owner |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
8,735,679 |
|
Indirect Shares
|
2,993,315 |
|
|
Direct
Value |
$167,786,021 |
|
|
Indirect Value
|
$16,134,065 |
|
|
Total
Shares |
11,728,994 |
|
|
Total
Value |
$183,920,086 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
Percentage
Gain/Loss : |
498.3%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Mattersight Corporation |
MATR |
10% Owner |
2003-09-26 |
0 |
2017-06-01 |
1,128,034 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director, 10% Owner |
2012-03-29 |
5,316,967 |
2011-10-21 |
229,567 |
Premium* |
|
Dextera Surgical Inc |
DXTR |
Director, 10% Owner |
2013-03-20 |
3,412,793 |
2013-03-20 |
170,977 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
Director |
2017-06-01 |
919 |
2017-06-01 |
377,782 |
Premium* |
|
Quinstreet, Inc |
QNST |
10% Owner |
|
0 |
2010-02-10 |
1,114 |
Premium* |
|
Horizon Pharma, Inc. |
HZNP |
Director |
2013-12-13 |
5,000 |
2013-12-13 |
178,406 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2020-07-02 |
0 |
2020-07-02 |
0 |
Premium* |
|
Yext Inc |
YEXT |
10% Owner |
|
0 |
2017-12-01 |
724,841 |
Premium* |
|
Venus Concept Inc |
VERO |
Director, 10% Owner |
2017-10-16 |
0 |
2017-10-16 |
182,594 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
143 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-12 |
4 |
B |
$6.45 |
$185,783 |
I/I |
28,791 |
20,052 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-13 |
4 |
B |
$6.58 |
$50,447 |
I/I |
7,667 |
20,251 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-14 |
4 |
B |
$6.61 |
$61,094 |
I/I |
9,245 |
20,491 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-15 |
4 |
B |
$6.65 |
$39,122 |
I/I |
5,881 |
20,644 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-16 |
4 |
B |
$6.60 |
$102,196 |
I/I |
15,487 |
21,046 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-19 |
4 |
B |
$6.65 |
$101,964 |
I/I |
15,333 |
21,444 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-20 |
4 |
B |
$6.63 |
$3,315 |
I/I |
500 |
785,607 |
1.42 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-21 |
4 |
B |
$6.76 |
$155,480 |
I/I |
23,000 |
22,041 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-22 |
4 |
B |
$6.56 |
$9,840 |
I/I |
1,500 |
809,510 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-23 |
4 |
B |
$7.03 |
$301,904 |
I/I |
42,950 |
23,157 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-27 |
4 |
B |
$7.53 |
$138,587 |
I/I |
18,413 |
23,635 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-28 |
4 |
B |
$7.83 |
$119,327 |
I/I |
15,243 |
24,031 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-29 |
4 |
B |
$8.11 |
$39,079 |
I/I |
4,818 |
24,156 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-30 |
4 |
B |
$8.32 |
$127,595 |
I/I |
15,333 |
24,554 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-06-02 |
4 |
B |
$8.71 |
$91,836 |
I/I |
10,541 |
24,828 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-09-12 |
4 |
A |
$5.67 |
$7,374,946 |
I/I |
1,300,696 |
56,285 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
10% Owner |
|
2008-11-11 |
4 |
A |
$0.00 |
$0 |
I/I |
70,136 |
88,215 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
10% Owner |
|
2009-02-06 |
4 |
B |
$0.69 |
$356,620 |
I/I |
519,097 |
105,402 |
1.5 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2009-10-05 |
4 |
B |
$1.91 |
$2,184,532 |
D/D |
1,143,734 |
3,678,983 |
3.92 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2009-10-05 |
4 |
B |
$1.91 |
$66,271 |
I/I |
34,697 |
111,116 |
2.25 |
- |
|
CORT |
Corcept Therapeutics Inc |
10% Owner |
|
2009-10-16 |
4 |
B |
$1.43 |
$29,816 |
I/I |
20,850 |
126,252 |
1.5 |
- |
|
CORT |
Corcept Therapeutics Inc |
10% Owner |
|
2010-04-21 |
4 |
OE |
$1.66 |
$12,115 |
I/I |
7,298 |
133,550 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2011-03-11 |
4 |
B |
$2.10 |
$44,020 |
I/I |
20,962 |
132,078 |
2.25 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2011-08-02 |
4 |
B |
$9.00 |
$1,290,015 |
I/I |
143,335 |
33,694 |
2.1 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2011-08-02 |
4 |
A |
$0.00 |
$1,416,258 |
I/I |
857,387 |
36,562 |
0 |
- |
|
143 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|